Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2023 | Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
2023 | Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 3 | |
+18.53% | 125B | |
+14.79% | 108B | |
-6.33% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-12.94% | 16.34B | |
+0.83% | 13.56B | |
+25.72% | 11.59B |
- Stock Market
- Equities
- NBRVF Stock
- News Nabriva Therapeutics plc
- J. Peter Wolf to Resign from Nabriva Therapeutics AG as General Counsel and Corporate Secretary